Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01829386 · ClinicalTrials.gov registry record

Non-Heme Iron Load Quantification in the Brain - MRI of Patients With Stroke

A clinical trial of Stroke, sponsored by University of Michigan.

Completed
Registry status
34
Enrollment target
1
Study location

NCT01829386: Completed study of Stroke, sponsored by University of Michigan.

NCT01829386 is a study of Stroke that has completed, run by University of Michigan. The registered enrollment target is 34 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01829386, a study of Stroke, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
34 participants
Enrollment target
1
Study location

Study Summary

This study will determine if MRI imaging can be used to estimate the amount of iron in areas of the brain affected by a stroke. This may help future patients if the scan can be used to predict the amount of brain damage and therefore the effects on the patient. New research treatments are being used to reduce the amount of iron build-up in the brain. The effects of that treatment may also be estimated using new MRI techniques.

Primary Outcome

Create a non-invasive imaging modality to assess for iron levels in patients with hemorrhagic stroke. Validation of quantification of non heme iron in the brain.

Conditions Studied

Interventions

  • OTHER MRI scans with non heme iron levels

Study Locations (1)

Michigan

  • University of Michigan Hospital - Ann Arbor

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2013-01
Est. Completion 2022-08-23
University of Michigan

1,327 total trials

What the finished NCT01829386 record still lists

NCT01829386 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which MRI scans with non heme iron levels is the first listed.

NCT01829386 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT01829386 about?

NCT01829386 is a clinical study titled "Non-Heme Iron Load Quantification in the Brain - MRI of Patients With Stroke". This study will determine if MRI imaging can be used to estimate the amount of iron in areas of the brain affected by a stroke. This may help future patients if the scan can be used to predict the amount of brain damage and therefore the effects on the patient. New research treatments are being use...

What is the current status of trial NCT01829386?

This trial is currently completed. The enrollment target is 34 participants. The study started on 2013-01. Estimated completion is 2022-08-23.

What conditions does trial NCT01829386 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT01829386?

The interventions under investigation include: MRI scans with non heme iron levels (OTHER).

Who is sponsoring clinical trial NCT01829386?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01829386 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01829386's enrollment target sits among peer trials

34 287th of 454 higher than 164 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02897063 · 34 participants · Phase 1

    Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

  • NCT03906617 · 34 participants · Phase 4

    Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine

  • NCT03992378 · 34 participants · NA

    Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis

  • NCT04047849 · 34 participants · Phase 4

    Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01829386, the US trial registry maintained by the National Library of Medicine. NCT01829386 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.